Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 247 citing Frickhofen: Persistent B19 parvovirus infection in patients infected with human immunodeficiency.... (0.11 sec) 

Erythrocyte P antigen: cellular receptor for B19 parvovirus


KE Brown, SM Anderson, NS Young - Science, 1993 - sciencemag.org
C. B. McKee, S. Steiger, G. Crater, Nucleic Acids Res. 15, 10031 (1987); J.
Noolandi, G. W. Slater, HA Lim, J. L. Viovy, Science 243, 1456 (1989); J.
Stellwagen and NC Stellwagen, Nucleic Acids Res. 17, 1537 (1989); D. C. ...
Cited by 451 - Related articles - BL Direct - All 6 versions

Inherited bone marrow failure syndromes


BP Alter, AD D'Andrea - Blood: Principles and Practice of Hematology, 1995 - books.google.com
PARTS Stem Cell Disorders CHAPTER 8 Inherited Bone Marrow Failure Syndromes
Blanche P. Alter and Alan D. D'Andréa Constitutional aplastic anemia was
defined by O'Gorman Hughes (1) as" chronic bone marrow failure associated ...
Cited by 430 - Related articles - BL Direct - All 4 versions

Human parvovirus B19

- nih.gov
ED Heegaard, KE Brown - Clinical Microbiology Reviews, 2002 - cmr.highwire.org
Parvovirus B19 (B19) was discovered in 1974 and is the only member of the family
Parvoviridae known to be pathogenic in humans. Despite the inability to
propagate the virus in cell cultures, much has been learned about the ...
Cited by 229 - Related articles - BL Direct - All 8 versions

Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen)


KE Brown, JR Hibbs, G Gallinella, SM … - The New England journal of medicine, 1994 - nejm.highwire.org
Results Of the 17 subjects with the p red-cell phenotype, who did not have P
antigen on their erythrocytes, none (0 of 11 and 0 of 6) had serologic evidence
of previous parvovirus B19 infection. In contrast, the seropositivity rates ...
Cited by 168 - Related articles - BL Direct - All 5 versions

Return to the past: the case for antibody-based therapies in infectious diseases


A Casadevall, MD Scharff - Clinical Infectious Diseases, 1995 - jstor.org
Return to the Past: The Case for ... From the Division of Infectious Diseases,
Department of Medicine and Department of Microbiology & Immunology, and the
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New ...
Cited by 133 - Related articles - BL Direct - All 3 versions

Passive immunity in prevention and treatment of infectious diseases

- angrylapdog.com
MA Keller, ER Stiehm - Clinical microbiology reviews, 2000 - Am Soc Microbiol
Antibodies have been used for over a century in the prevention and treatment of
infectious disease. They are used most commonly for the prevention of measles,
hepatitis A, hepatitis B, tetanus, varicella, rabies, and vaccinia. ...
Cited by 118 - Related articles - BL Direct - All 10 versions

Parvovirus B19 as a possible causative agent of fulminant liver failure and associated …


AN Langnas, RS Markin, MS Cattral, SJ … - Hepatology, 1995 - interscience.wiley.com
We recently observed that more than one third of pediatric patients who
presented with non-A, non-B fulminant liver failure (FLF) also developed
aplastic anemia (AA) either before or shortly after liver transplantation. ...
Cited by 107 - Related articles - BL Direct - All 3 versions

USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected …


JE Kaplan, H Masur, KK Holmes, CM Wilfert, … - Clinical infectious diseases, 1995 - jstor.org
The USPHS/IDSA Prevention of Opportunistic Infections Working Group has recently
formulated disease-specific rec- ommendations for 17 opportunistic infections
(OIs) or groups of OIs in HIV-infected persons [1]. The purpose of this ...
Cited by 101 - Related articles - BL Direct - All 8 versions

Frequency of human parvovirus B19 infection in intrauterine fetal death


T Tolfvenstam, N Papadogiannakis, O Norbeck … - The Lancet, 2001 - Elsevier
Parvovirus B19 is known to cause fetal death in the second trimester, mainly in
combination with hydrops fetalis. However, the frequency of
parvovirus-B19-associated non-hydropic fetal loss in the late second and ...
Cited by 96 - Related articles - BL Direct - All 6 versions

Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 …

- nih.gov [PDF] 
JR Mascola, MK Louder, TC VanCott, CV … - The Journal of Virology, 1997 - jvi.highwire.org
Page 1. J OURNAL OF V IROLOGY , 0022-538X/97/$04.00 0 Oct. 1997, p. 7198–7206 Vol.
71, No. 10 Copyright © 1997, American Society for Microbiology ...
Cited by 95 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google